QuantaMatrix

QuantaMatrix Liabilities

The The Liabilities of QuantaMatrix (317690.KQ) as of Nov 5, 2026 is 12.67 B KRW. In the previous year, The Liabilities was 20.30 B KRW — a change of -37.59% (lower).

Liabilities

12.67 BKRW

YoY

-37.59%

Last updated:

In 2025, QuantaMatrix's total liabilities amounted to 12.67 B KRW, a -37.59% difference from the 20.30 B KRW total liabilities in the previous year.

The QuantaMatrix Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
71.96 B KRW
Jan 1, 2019
3.91 B KRW
Jan 1, 2020
4.15 B KRW
Jan 1, 2021
5.38 B KRW
Jan 1, 2022
5.72 B KRW
Jan 1, 2023
4.55 B KRW
Jan 1, 2024
20.30 B KRW
Jan 1, 2025
12.67 B KRW
The QuantaMatrix Liabilities history
YEARLiabilitiesYoY
12.67 BKRW-37.59%
20.30 BKRW+346.42%
4.55 BKRW-20.49%
5.72 BKRW+6.37%
5.38 BKRW+29.42%
4.15 BKRW+6.20%
3.91 BKRW-94.57%
71.96 BKRW+78.06%
40.41 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

QuantaMatrix Stock analysis

What does QuantaMatrix do? QuantaMatrix Inc. generates revenue through the sale of its multi-diagnostic unique test platform, micro disc, antimicrobial susceptibility testing sepsis diagnostic equipment, molecular immunity diagnosis automation platform, rapid antituberculosis susceptibility testing equipment, and rapid antituberculosis susceptibility testing kits. The company also sells covid kits and conducts research and development for microbial diagnostic products. Its primary customers include healthcare facilities and laboratories requiring advanced diagnostic solutions for microbiological and molecular testing. The firm targets segments focused on infectious disease diagnostics, antimicrobial resistance testing, and rapid tuberculosis detection. The company's product portfolio emphasizes innovative diagnostic tools, with a strong focus on sepsis diagnostics and tuberculosis testing. By offering both equipment and kits, QuantaMatrix addresses diverse needs within the healthcare sector. The firm's research and development activities support continuous product enhancement and expansion into new diagnostic areas. QuantaMatrix Inc. serves the global market for diagnostic equipment, with particular emphasis on regions where infectious disease management is critical. Its products are designed to meet the demands of healthcare providers seeking efficient, accurate, and rapid diagnostic solutions. The company's strategy centers on leveraging its technological expertise to capture market share in specialized diagnostic segments. QuantaMatrix is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing QuantaMatrix's Liabilities

QuantaMatrix's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating QuantaMatrix's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing QuantaMatrix's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

QuantaMatrix's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in QuantaMatrix’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about QuantaMatrix stock

The Liabilities of QuantaMatrix is 12.67 B KRW in 2025.

The Liabilities of QuantaMatrix changed from 20.30 B KRW to 12.67 B KRW, representing a -37.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities QuantaMatrix since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's QuantaMatrix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — QuantaMatrix

All Key Metrics — QuantaMatrix